Faculty

Back to Index
Eunjung Lee, PhD
Assistant Professor of Research Preventive Medicine
Preventive Medicine
NOR 4417A 1441 Eastlake Avenue Health Sciences Campus Los Angeles
+1 323 865 0827

Overview

My primary research interests are in understanding the interplay of environmental factors interacting with molecular, genetic and epigenetic factors to influence chronic disease risk such as cancer.

Publications

Stomach Cancer Disparity among Korean Americans by Tumor Characteristics: Comparison with Non-Hispanic Whites, Japanese Americans, South Koreans, and Japanese. Cancer Epidemiol Biomarkers Prev. 2017 Apr; 26(4):587-596. View in: PubMed

Stomach cancer disparity among Korean Americans by tumor characteristics: comparison with non-Hispanic whites, Japanese Americans, South Koreans, and Japanese. Cancer Epidemiol Biomarkers Prev. 2016 Dec 01. View in: PubMed

Recreational physical activity and risk of triple negative breast cancer in the California Teachers Study. Breast Cancer Res. 2016 Jun 17; 18(1):62. View in: PubMed

Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry. Cancer Causes Control. 2016 May; 27(5):679-93. View in: PubMed

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer. Nat Commun. 2016 Apr 27; 7:11375. View in: PubMed

Novel polymorphisms in caspase-8 are associated with breast cancer risk in the California Teachers Study. BMC Cancer. 2016 Jan 12; 16:14. View in: PubMed

Novel polymorphisms in caspase-8 are associated with breast cancer risk in the California Teachers Study. BMC Cancer. 2016; 16:14. View in: PubMed

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer. Nat Commun. 2016; 7:11375. View in: PubMed

Recreational physical activity and risk of triple negative breast cancer in the California Teachers Study. Breast Cancer Res. 2016; 18(1):62. View in: PubMed

Pleiotropic analysis of cancer risk loci on esophageal adenocarcinoma risk. Cancer Epidemiol Biomarkers Prev. 2015 Nov; 24(11):1801-3. View in: PubMed

Hormone metabolism pathway genes and mammographic density change after quitting estrogen and progestin combined hormone therapy in the California Teachers Study. Breast Cancer Res. 2014 Dec 11; 16(6):477. View in: PubMed

Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade. Hum Mol Genet. 2014 Nov 15; 23(22):6034-46. View in: PubMed

Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade. Hum Mol Genet. 2014 Jun 13. View in: PubMed

Estimating risks for variants of unknown significance according to their predicted pathogenicity classes with application to BRCA1. Breast Cancer Res Treat. 2014 Feb; 144(1):171-7. View in: PubMed

Hormone metabolism pathway genes and mammographic density change after quitting estrogen and progestin combined hormone therapy in the California Teachers Study. Breast Cancer Res. 2014; 16(6):477. View in: PubMed

Reproductive factors, exogenous hormones, and pancreatic cancer risk in the CTS. Am J Epidemiol. 2013 Nov 01; 178(9):1403-13. View in: PubMed

Reproductive factors, exogenous hormones, and pancreatic cancer risk in the CTS. Am J Epidemiol. 2013 Nov 1; 178(9):1403-13. View in: PubMed

Hormone metabolism genes and mammographic density in Singapore Chinese women. Cancer Epidemiol Biomarkers Prev. 2013 May; 22(5):984-6. View in: PubMed

Genetic variation in transforming growth factor beta 1 and mammographic density in Singapore Chinese women. Cancer Res. 2013 Mar 15; 73(6):1876-82. View in: PubMed

Variation in inflammatory cytokine/growth-factor genes and mammographic density in premenopausal women aged 50-55. PLoS One. 2013; 8(6):e65313. View in: PubMed

Soy isoflavones and breast cancer. Am Soc Clin Oncol Educ Book. 2013; 102-6. View in: PubMed

Soy isoflavones and breast cancer. Am Soc Clin Oncol Educ Book. 2013; 33:102-6. View in: PubMed

Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2012 Jul; 21(7):1156-66. View in: PubMed

Genetic variation in peroxisome proliferator-activated receptor gamma, soy, and mammographic density in Singapore Chinese women. Cancer Epidemiol Biomarkers Prev. 2012 Apr; 21(4):635-44. View in: PubMed

Variations in sex hormone metabolism genes, postmenopausal hormone therapy and risk of endometrial cancer. Int J Cancer. 2012 Apr 1; 130(7):1629-38. View in: PubMed

Variations in sex hormone metabolism genes, postmenopausal hormone therapy and risk of endometrial cancer. Int J Cancer. 2012 Apr 01; 130(7):1629-38. View in: PubMed

Characteristics of triple-negative breast cancer in patients with a BRCA1 mutation: results from a population-based study of young women. J Clin Oncol. 2011 Nov 20; 29(33):4373-80. View in: PubMed

The association of polymorphisms in hormone metabolism pathway genes, menopausal hormone therapy, and breast cancer risk: a nested case-control study in the California Teachers Study cohort. Breast Cancer Res. 2011 Apr 01; 13(2):R37. View in: PubMed

GRP78 as potential predictor for breast cancer response to adjuvant taxane therapy. Int J Cancer. 2011 Feb 01; 128(3):726-31. View in: PubMed

GRP78 as potential predictor for breast cancer response to adjuvant taxane therapy. Int J Cancer. 2011 Feb 1; 128(3):726-31. View in: PubMed

The association of polymorphisms in hormone metabolism pathway genes, menopausal hormone therapy, and breast cancer risk: a nested case-control study in the California Teachers Study cohort. Breast Cancer Res. 2011; 13(2):R37. View in: PubMed

Menopausal hormone therapy and subsequent risk of specific invasive breast cancer subtypes in the California Teachers Study. Cancer Epidemiol Biomarkers Prev. 2010 Sep; 19(9):2366-78. View in: PubMed

Genetic variation in the progesterone receptor gene and risk of endometrial cancer: a haplotype-based approach. Carcinogenesis. 2010 Aug; 31(8):1392-9. View in: PubMed

Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study. Cancer Epidemiol Biomarkers Prev. 2008 Nov; 17(11):3170-8. View in: PubMed

Evaluation of unclassified variants in the breast cancer susceptibility genes BRCA1 and BRCA2 using five methods: results from a population-based study of young breast cancer patients. Breast Cancer Res. 2008; 10(1):R19. View in: PubMed

The role of established breast cancer susceptibility loci in mammographic density in young women. Cancer Epidemiol Biomarkers Prev. 2008 Jan; 17(1):258-60. View in: PubMed

GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer. Cancer Res. 2006 Aug 15; 66(16):7849-53. View in: PubMed

Mitogen-activated protein kinase kinase inhibitor PD98059 blocks the trans-activation but not the stabilization or DNA binding ability of hypoxia-inducible factor-1alpha. Mol Pharmacol. 2001 May; 59(5):1216-24. View in: PubMed

Powered bySC CTSI